Literature DB >> 2229924

Panax ginseng as a potential immunomodulator: studies in mice.

J Y Kim1, D R Germolec, M I Luster.   

Abstract

There has been continuing interest in the development of synthetic and natural compounds which modify the immune response, particularly for the treatment of AIDS and cancer. Panax ginseng, employed for its putative medicinal properties in South Asia, was examined for its immunomodulatory properties in mice. A systematic evaluation of multiple immune system components revealed that Panax ginseng stimulated basal natural killer (NK) cell activity following subchronic exposure and helped stimulate recovery of NK function in cyclophosphamide-immunosuppressed mice but did not further stimulate NK activity in poly I:C treated mice. Other immunological parameters examined, including T and B cell responses were not affected. Panax ginseng provided a degree of protection against infection with L. monocytes but did not inhibit the growth of transplanted syngeneic tumor cells. Increased resistance to L. monocytogenes was not detected in challenged mice previously given immunosuppressive doses of cyclophosphamide. Taken together, these data suggest that Panax ginseng has some immunomodulatory properties, primarily associated with NK cell activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229924     DOI: 10.3109/08923979009019672

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  17 in total

1.  Stimulation of nitric oxide synthesis by the aqueous extract of Panax ginseng root in RAW 264.7 cells.

Authors:  R Friedl; T Moeslinger; B Kopp; P G Spieckermann
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 2.  Potential neuroprotective activity of Ginseng in Parkinson's disease: a review.

Authors:  Elena González-Burgos; Carlos Fernandez-Moriano; M Pilar Gómez-Serranillos
Journal:  J Neuroimmune Pharmacol       Date:  2014-10-29       Impact factor: 4.147

3.  Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial.

Authors:  Gerald N Predy; Vinti Goel; Ray Lovlin; Allan Donner; Larry Stitt; Tapan K Basu
Journal:  CMAJ       Date:  2005-10-25       Impact factor: 8.262

4.  pS2 expression induced by American ginseng in MCF-7 breast cancer cells.

Authors:  R B Duda; B Taback; B Kessel; D D Dooley; H Yang; J Marchiori; B M Slomovic; J G Alvarez
Journal:  Ann Surg Oncol       Date:  1996-11       Impact factor: 5.344

5.  Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common cold.

Authors:  Mostafa Yakoot; Amel Salem
Journal:  Int J Gen Med       Date:  2011-01-12

6.  Effect of Ginseng on Calretinin Expression in Mouse Hippocampus Following Exposure to 835 MHz Radiofrequency.

Authors:  Bijay Aryal; Dhiraj Maskey; Myeung-Ju Kim; Jae-Won Yang; Hyung-Gun Kim
Journal:  J Ginseng Res       Date:  2011-06       Impact factor: 6.060

7.  Chemical Diversity of Panax ginseng, Panax quinquifolium, and Panax notoginseng.

Authors:  Dong-Hyun Kim
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

8.  Ginseng, the 'Immunity Boost': The Effects of Panax ginseng on Immune System.

Authors:  Soowon Kang; Hyeyoung Min
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

9.  Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial.

Authors:  Chang-Seop Lee; Ju-Hyung Lee; Mira Oh; Kyung-Min Choi; Mi Ran Jeong; Jong-Dae Park; Dae Young Kwon; Ki-Chan Ha; Eun-Ock Park; Nuri Lee; Sun-Young Kim; Eun-Kyung Choi; Min-Gul Kim; Soo-Wan Chae
Journal:  J Korean Med Sci       Date:  2012-12-07       Impact factor: 2.153

10.  Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells.

Authors:  Davy C W Lee; Cindy L H Yang; Stanley C C Chik; James C B Li; Jian-hui Rong; Godfrey C F Chan; Allan S Y Lau
Journal:  J Transl Med       Date:  2009-05-14       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.